Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

Similar articles for PubMed (Select 22489102)

1.

Significant Correlation between Chromosomal Aberration and Nuclear Morphology in Urothelial Carcinoma.

Shuto M, Seyama A, Gotoh Y, Kamada K, Nakamura M, Warigaya K, Watanabe H, Ueno M, Shimizu M, Fukuda T, Murata S.

Acta Histochem Cytochem. 2012 Feb 29;45(1):25-33. doi: 10.1267/ahc.11048. Epub 2012 Jan 24.

2.

Chromosomal instability and bladder cancer: the UroVysion(TM) test in the UroScreen study.

Bonberg N, Taeger D, Gawrych K, Johnen G, Banek S, Schwentner C, Sievert KD, Wellhäußer H, Kluckert M, Leng G, Nasterlack M, Stenzl A, Behrens T, Brüning T, Pesch B; UroScreen Study Group.

BJU Int. 2013 Aug;112(4):E372-82. doi: 10.1111/j.1464-410X.2012.11666.x. Epub 2013 Jan 25.

PMID:
23350736
3.

Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.

Schwarz S, Rechenmacher M, Filbeck T, Knuechel R, Blaszyk H, Hartmann A, Brockhoff G.

J Clin Pathol. 2008 Mar;61(3):272-7. Epub 2007 Aug 10.

PMID:
17693577
4.

Multicolor FISH and cytometric analyses allow classification of urothelial carcinomas into two subtypes, low- and high-grade tumors.

Ikemoto K, Furuya T, Matsuda K, Kawauchi S, Oga A, Ikeda J, Liu XP, Sasaki K.

Int J Oncol. 2004 Oct;25(4):893-8.

PMID:
15375537
5.

Chromosomal abnormalities in renal cell carcinoma variants detected by Urovysion fluorescence in situ hybridization on paraffin-embedded tissue.

Reid-Nicholson MD, Motiwala N, Drury SC, Peiper SC, Terris MK, Waller JL, Ramalingam P.

Ann Diagn Pathol. 2011 Feb;15(1):37-45. doi: 10.1016/j.anndiagpath.2010.07.011.

PMID:
21238914
6.

The use of Urovysion fluorescence in situ hybridization in the diagnosis and surveillance of non-urothelial carcinoma of the bladder.

Reid-Nicholson MD, Ramalingam P, Adeagbo B, Cheng N, Peiper SC, Terris MK.

Mod Pathol. 2009 Jan;22(1):119-27. doi: 10.1038/modpathol.2008.179. Epub 2008 Oct 31.

8.

Chromosomal alterations detected by fluorescence in situ hybridization in urothelial carcinoma and rarer histologic variants of bladder cancer.

Kipp BR, Tyner HL, Campion MB, Voss JS, Karnes RJ, Sebo TJ, Halling KC, Zhang J.

Am J Clin Pathol. 2008 Oct;130(4):552-9. doi: 10.1309/DFJUHY3WPC9GUU2W.

9.

[Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].

Xiao L, Wang CF, Zhu XZ, Yin YL, Chen Y, Lu C, Yu B.

Zhonghua Bing Li Xue Za Zhi. 2011 May;40(5):319-23. Chinese.

PMID:
21756826
10.

Correlation between histologic findings and cytogenetic abnormalities in bladder carcinoma: a FISH study.

Placer J, Espinet B, Salido M, Solé F, Gelabert-Mas A.

Urology. 2005 May;65(5):913-8.

PMID:
15882723
11.

[Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].

Zhang YG, Bi XG, Han YL, Cai Y, Xu X, Wu YP, Yang YL, Ma JH, Zhao P, Jia XM, Wang MR.

Ai Zheng. 2007 Feb;26(2):189-93. Chinese.

PMID:
17298751
12.

Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis.

Jones TD, Zhang S, Lopez-Beltran A, Eble JN, Sung MT, MacLennan GT, Montironi R, Tan PH, Zheng S, Baldridge LA, Cheng L.

Am J Surg Pathol. 2007 Dec;31(12):1861-7.

PMID:
18043040
13.

UroVysion® multiprobe FISH in the triage of equivocal urinary cytology cases.

Bubendorf L, Piaton E.

Ann Pathol. 2012 Dec;32(6):e52-6, 438-43. doi: 10.1016/j.annpat.2012.09.207. Epub 2012 Nov 24. Review. English, French.

PMID:
23244486
15.

[Molecular changes in development and progression of urothelial carcinoma].

Hartmann A.

Verh Dtsch Ges Pathol. 2003;87:172-84. Review. German.

PMID:
16888910
16.

p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.

Yin M, Bastacky S, Parwani AV, McHale T, Dhir R.

Hum Pathol. 2008 Apr;39(4):527-35. doi: 10.1016/j.humpath.2007.08.005. Epub 2008 Jan 30.

PMID:
18234280
17.
18.

A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma.

Halling KC, King W, Sokolova IA, Meyer RG, Burkhardt HM, Halling AC, Cheville JC, Sebo TJ, Ramakumar S, Stewart CS, Pankratz S, O'Kane DJ, Seelig SA, Lieber MM, Jenkins RB.

J Urol. 2000 Nov;164(5):1768-75.

PMID:
11025767
19.

Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.

Veeramachaneni R, Nordberg ML, Shi R, Herrera GA, Turbat-Herrera EA.

Diagn Cytopathol. 2003 Jun;28(6):301-7.

PMID:
12768634
20.

9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology.

Kawauchi S, Sakai H, Ikemoto K, Eguchi S, Nakao M, Takihara H, Shimabukuro T, Furuya T, Oga A, Matsuyama H, Takahashi M, Sasaki K.

Hum Pathol. 2009 Dec;40(12):1783-9. doi: 10.1016/j.humpath.2009.06.011. Epub 2009 Sep 5.

PMID:
19733894
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk